14. Darrow TL, Slingluff Jr CL, Seigler HF: The role of HLA class I 
antigens in recognition of melanoma cells by tumor-specific cytotoxic T 
lymphocytes. J Immunology 142:3329-3335, 1989. 
15. Crowley NJ, Slingluff Jr CL, Darrow TL et al: Generation of human 
autologous melanoma-specific cytotoxic T-cells using HLA-A2-matched 
allogeneic melanomas. Cancer Res 50:492-498, 1990. 
16. Kawakami Y, Zakut R, Topalian SL et al: Shared human melanoma antigens. 
Recognition by tumor infiltrating lymphocyte in HLA-A2 . 1-trans fected 
melanomas. J Immunology 148:638-643, 1992. 
17. Slingluff Jr CL, Cox AL, Henderson RA et al: Recognition of human 
melanoma cells by HLA-A2 . 1-restricted cytotoxic T lymphocytes is 
mediated by at least six shared peptide epitopes. J Immunology 
150:2995-2963, 1993. 
18. van der Bruggen P, Traversari C, Chomez P et al: A gene encoding an 
antigen recognized by cytolytic T lymphocytes on a human melanoma. 
Science: 1643-1647, 1991. 
19. Crowley NJ, Vervaert CE, Seigler HF: Human xenograft-nude mouse model 
of adoptive immunotherapy with human melanoma-specific cytotoxic T- 
cells. Cancer Res 52:394-399, 1992. 
20. Schwartz RH: Costimulation of T lymphocytes: the role of CD28, CTLA-4, 
and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71:1065- 
1068, 1992. 
21. Townsend SE, Allison JP: Tumor rejection after direct costimulation of 
CD8 + T cells by B7-trans fected melanoma cells. Science 259:368-370, 
1993. 
22. Chen L, Ashe S, Brady WA et al: Costimulation of antitumor immunity by 
the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. 
Cell 71:1093-1102, 1992. 
23. Sondak VK, Wagner PD, Shu S et al: Suppressive effects of visceral 
tumor on the generation of antitumor T cells for adoptive immunotherapy. 
Arch Surg 126:442-446, 1991. 
24. Mizoguchi H, O'Shea JJ, Longo DL et al: Alterations in signal 
transduction molecules in T lymphocytes from tumor-bearing mice. 
Science 258:1795-1798, 1992. 
25. Coulie PG, Somville M, Lehmann F et al: Precursor frequency analysis of 
human cytolytic T lymphocytes directed against autologous melanoma 
cells. Int J Cancer 50:289-297, 1992. 
[740] Recombinant DNA Research, Volume 18 
